Advances in Engineered Phages for Disease Treatment
Small Methods · 2025-05 · 9 (5)
DOI: 10.1002/smtd.202401611 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Small Methods, online erschienen am 11.02.2025. Verfasst von Xiaolin Hou und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Biopharmaceutical Preparation and Delivery Institute of Process Engineering, Chinese Academy of Sciences, Bejing, 100190, P. …. Hauptthemen laut MEDLINE: Phage Therapy, Bacteriophages, Bacterial Infections. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 119 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Phage therapy presents a promising solution for combating multidrug‐resistant (MDR) bacterial infections and other bacteria‐related diseases, attributed to their innate ability to target and lyse bacteria. Recent clinical successes, particularly in treating MDR‐related respiratory and post‐surgical infections, validated the therapeutic potential of phage therapy. However, the complex microenvironment within the human body poses significant challenges to phage activity and efficacy in vivo. To overcome these barriers, recent advances in phage engineering have aimed to enhance targeting accuracy, improve stability and survivability, and explore synergistic combinations with other therapeutic modalities. This review provides a comprehensive overview of phage therapy, emphasizing the application of engineered phages in antibacterial therapy, tumor therapy, and vaccine development. Furthermore, the review highlights the current challenges and future trends for advancing phage therapy toward broader clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Biopharmaceutical Preparation and Delivery Institute of Process Engineering, Chinese Academy of Sciences, Bejing, 100190, P. R. China.
- School of Chemical Engineering, University of Chinese Academy of Sciences, Beijing, 100049, P. R. China.
ORCID-Profile: Guanghui Ma
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Hou, X., Zhai, L., Fu, L., Lu, J., Guo, P., Zhang, Y., Zheng, D., & Ma, G. (2025). Advances in Engineered Phages for Disease Treatment. Small Methods, 9(5). https://doi.org/10.1002/smtd.202401611
Vancouver
Hou X, Zhai L, Fu L, Lu J, Guo P, Zhang Y, et al. Advances in Engineered Phages for Disease Treatment. Small Methods. 2025;9(5). doi:10.1002/smtd.202401611
BibTeX
@article{Hou2025,
author = {Hou, Xiaolin and Zhai, Lin and Fu, Laiying and Lu, Junna and Guo, Peilin and Zhang, Yu and Zheng, Diwei and Ma, Guanghui},
title = {Advances in Engineered Phages for Disease Treatment},
journal = {Small Methods},
year = {2025},
volume = {9},
number = {5},
doi = {10.1002/smtd.202401611}
}
EUVIMED